Ogluo 1 mg oplossing voor injectie in voorgevulde spuit
As listed in the register: Ogluo 1 mg oplossing voor injectie in voorgevulde spuit
1 mg · oplossing voor injectie
- Prescription only
- Hormones, such as thyroid and steroids
- Active substance
- Glucagon
- Made by
- Strongbridge Dublin Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Baqsimi). It describes the substance, not this exact product.
Glucagon increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating glycogen breakdown and release of glucose from the liver.
Hepatic stores of glycogen are necessary for glucagon to produce an antihypoglycemic effect.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-06-19
Safety of the active substance
From the US prescribing label for the same active substance (Baqsimi). It describes the substance, not this exact product.
- BAQSIMI is contraindicated in patients with: Pheochromocytoma because of the risk of substantial increase in blood pressure [see Warnings and Precautions ( 5.1 )] Insulinoma because of the risk of hypoglycemia [see Warnings and Precautions ( 5.2 )] Prior hypersensitivity reaction to glucagon or to any of the excipients in BAQSIMI.
- Allergic reactions have been reported with glucagon and include anaphylactic shock with breathing difficulties and hypotension [see Warnings and Precautions ( 5.3 )] Pheochromocytoma ( 4 ) Insulinoma ( 4 ) Known hypersensitivity to glucagon or to any of the excipients ( 4 )
Most common (≥10%) adverse reactions associated with BAQSIMI are nausea, vomiting, headache, upper respiratory tract irritation (i.e., rhinorrhea, nasal discomfort, nasal congestion, cough, and epistaxis), watery eyes, redness of eyes, itchy nose, throat and eyes.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States1 matching products
European UnionNo exact match for this strength and form
Spain1 matching products
FranceNo exact match for this strength and form
CanadaNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Strongbridge Dublin Limited |
|---|---|
| Active substance | Glucagon |
| Used in | Hormones, such as thyroid and steroids |
| Strength | 1 mg |
| Form | oplossing voor injectie |
| Classification | H04AA01 · Hormones, such as thyroid and steroids |
| Route | subcutaan gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| RVG | EU/1/20/1523 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.